Clinical Trial Update: Safety and Proof of Concept Study of ANXV (Annexin A5) in Patients With Diabetic Retinopathy or Retinal Vein Occlusion [Phase 2]

View source ↗

Summary

Clinical trial update for a Phase 2 safety and proof-of-concept study of ANXV (Annexin A5) in patients with non-proliferative diabetic retinopathy or retinal ve…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-proliferative Diabetic Retinopathy
• Retinal Vein Occlusion

Drugs mentioned

• ANXV (Annexin A5)

Snippet

Sponsor: Annexin Pharmaceuticals AB | Conditions: Non-Proliferative Diabetic Retinopathy, Retinal Vein Occlusion | Phase 2 | Status: RECRUITING